{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:31:52Z","timestamp":1790947912188,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jtha.2025.08.005","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T02:16:36Z","timestamp":1755742596000},"page":"3648-3653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Absorption of apixaban following metabolic and bariatric surgery: is reluctance still warranted?"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9702-1160","authenticated-orcid":false,"given":"Claudia","family":"Berends","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5062-9331","authenticated-orcid":false,"given":"Cedric","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8096-0188","authenticated-orcid":false,"given":"Laura","family":"Heusschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Hovens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Witteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-3334","authenticated-orcid":false,"given":"Eric","family":"Hazebroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshang","family":"Monajemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.08.005_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.15386\/mpr-1372","article-title":"Association between obesity and venous thromboembolism","volume":"93","author":"Hotoleanu","year":"2020","journal-title":"Med Pharm Rep"},{"key":"10.1016\/j.jtha.2025.08.005_bib2","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/archinte.168.15.1678","article-title":"Overweight, obesity, and the risk of recurrent venous thromboembolism","volume":"168","author":"Eichinger","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2025.08.005_bib3","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3390\/nu14091878","article-title":"Body mass index and the risk of atrial fibrillation: a mendelian randomization study","volume":"14","author":"Ma","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jtha.2025.08.005_bib4","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1007\/s11695-024-07196-3","article-title":"Metabolic bariatric surgery across the IFSO chapters: key insights on the baseline patient demographics, procedure types, and mortality from the Eighth IFSO Global Registry Report","volume":"34","author":"Brown","year":"2024","journal-title":"Obes Surg"},{"key":"10.1016\/j.jtha.2025.08.005_bib5","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jth.15823","article-title":"Direct oral anticoagulants after bariatric surgery\u2014what is the evidence?","volume":"20","author":"Leong","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.005_bib6","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/jth.15358","article-title":"Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation","volume":"19","author":"Martin","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.005_bib7","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1007\/s11695-023-06770-5","article-title":"Impact of bariatric surgery in the short and long term: a need for time-dependent dosing of drugs","volume":"33","author":"Lau","year":"2023","journal-title":"Obes Surg"},{"key":"10.1016\/j.jtha.2025.08.005_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.amjcard.2020.09.020","article-title":"Safety and efficacy of oral anticoagulants for atrial fibrillation in patients after bariatric surgery","volume":"136","author":"Hendricks","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2025.08.005_bib9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/phar.1307","article-title":"Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapy","volume":"33","author":"Irwin","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jtha.2025.08.005_bib10","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.soard.2017.12.021","article-title":"Adjustments to warfarin dosing after gastric bypass and sleeve gastrectomy","volume":"14","author":"Strong","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jtha.2025.08.005_bib11","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2147\/PPA.S204246","article-title":"Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study","volume":"13","author":"Ng","year":"2019","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jtha.2025.08.005_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.thromres.2017.11.006","article-title":"The effect of bariatric surgery on direct-acting oral anticoagulant drug levels","volume":"163","author":"Rottenstreich","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.08.005_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.thromres.2024.01.007","article-title":"Pharmacokinetics of direct oral anticoagulants after bariatric surgery: a retrospective cohort study","volume":"235","author":"Gunka","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.08.005_bib15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11695-021-05814-y","article-title":"Anti-Xa levels in morbidly obese patients using apixaban or rivaroxaban, before and after bariatric surgery","volume":"32","author":"Kok","year":"2022","journal-title":"Obes Surg"},{"key":"10.1016\/j.jtha.2025.08.005_bib16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.005_bib17","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.005_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.soard.2022.09.010","article-title":"Outcomes with direct-acting oral anticoagulants in patients with a history of bariatric surgery: a retrospective cohort study","volume":"19","author":"Langworthy","year":"2023","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jtha.2025.08.005_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/bloodadvances.2021006696","article-title":"Direct oral Xa inhibitors for the treatment of venous thromboembolism after bariatric surgery","volume":"7","author":"Kushnir","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.08.005_bib20","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S2352-3026(18)30191-1","article-title":"Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis","volume":"6","author":"Dawwas","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.08.005_bib21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.soard.2021.12.023","article-title":"The APB study: apixaban pharmacokinetics in bariatric patients before to 1 year after vertical sleeve gastrectomy or Roux-en-Y gastric bypass","volume":"18","author":"Steele","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jtha.2025.08.005_bib22","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.amjmed.2021.06.021","article-title":"Thromboembolism, bleeding, and mortality incidence of direct oral anticoagulants versus warfarin postbariatric surgery","volume":"134","author":"Srivastava","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2025.08.005_bib23","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1007\/s11695-023-06910-x","article-title":"Long-term outcomes of bariatric surgery in patients on chronic anticoagulation","volume":"33","author":"Abi Mosleh","year":"2023","journal-title":"Obes Surg"},{"key":"10.1016\/j.jtha.2025.08.005_bib24","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.33963\/KP.a2021.0165","article-title":"Direct oral anticoagulants in patients with atrial fibrillation following bariatric surgery: a single center experience","volume":"79","author":"Hanarz","year":"2021","journal-title":"Kardiol Pol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625005240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625005240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:10:59Z","timestamp":1778818259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625005240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1538783625005240"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.08.005","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absorption of apixaban following metabolic and bariatric surgery: is reluctance still warranted?","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}